🔎 Trials Near Me

Akèy › Sarkom tisi mou › Tennessee › Memphis

Etid klinik pou Sarkom tisi mou nan Memphis, TN

11 etid pou Sarkom tisi mou ap chèche patisipan nan sit nan ak bò kote Memphis (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.

Tèks ofisyèl etid la (Anglè)

Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →

A Study of Repotrectinib in Pediatric and Young Adult Subjects Harboring ALK, ROS1, OR NTRK1-3 Alterations

Ap rekriteFaz 1/2
  • St. Jude Children's Research Hospital, Memphis
Jiska laj 25 · Tout sèks · Mizajou Sep 25, 2026 · NCT04094610

Integration of Adaptive Proton Therapy in Pediatric Solid Tumors and Hodgkin's Lymphoma

Ap rekrite
  • St. Jude Children's Research Hospital, Memphis
Tout laj · Tout sèks · Mizajou Aug 21, 2026 · NCT07514819

NRSTS2021, A Risk Adapted Study Evaluating Maintenance Pazopanib, Limited Margin, Dose-Escalated Radiation Therapy and Selinexor in Non-Rhabdomyosarcoma Soft Tissue Sarcoma (NRSTS)

Ap rekriteFaz 1/2
  • St. Jude Children's Research Hospital, Memphis
Jiska laj 30 · Tout sèks · Mizajou Aug 3, 2026 · NCT06239272

Deep Phenotyping Gait Deficits in Orthopedic Manifestations of Pediatric Cancer Patients

Ap rekriteEtid obsèvasyonVolontè an sante akeyi
  • St. Jude Children's Research Hospital, Memphis
Laj 5 a 20 · Tout sèks · Mizajou Jun 18, 2026 · NCT07502885

A Study of Repotrectinib (TPX-0005) in Patients With Advanced Solid Tumors Harboring ALK, ROS1, or NTRK1-3 Rearrangements

Ap rekriteFaz 1/2
  • Baptist Memorial Hospital Baptist Cancer Center, Memphis
Laj 12 ak plis · Tout sèks · Mizajou May 27, 2026 · NCT03093116

B7-H3-Specific Chimeric Antigen Receptor Autologous T-Cell Therapy for Pediatric Patients With Solid Tumors (3CAR)

Ap rekriteFaz 1
  • St. Jude Children's Research Hospital, Memphis
Jiska laj 21 · Tout sèks · Mizajou May 19, 2026 · NCT04897321

Study of Onivyde With Talazoparib or Temozolomide in Children With Recurrent Solid Tumors and Ewing Sarcoma

Ap rekriteFaz 1/2
  • St. Jude Children's Research Hospital, Memphis
12 Months – 30 Years · Tout sèks · Mizajou May 19, 2026 · NCT04901702

Hypofractionated Radiation in Combination With B7-H3-CAR T Cells for Pediatric Patients With Relapsed/Refractory Sarcomas

Ap rekriteFaz 1
  • St. Jude Children's Research Hospital, Memphis
Jiska laj 21 · Tout sèks · Mizajou Feb 9, 2026 · NCT07222735

Study of Lurbinectedin Monotherapy in Pediatric and Young Adult Participants With Relapsed/Refractory Ewing Sarcoma

Ap rekriteFaz 1/2
  • St. Jude Children's Research Hospital, Memphis
Laj 2 a 30 · Tout sèks · Mizajou Feb 3, 2026 · NCT05734066

cfDNA Assay Prospective Observational Validation for Early Cancer Detection and Minimal Residual Disease

Ap rekriteEtid obsèvasyonVolontè an sante akeyi
  • Baptist (BHMCC), Memphis
Laj 40 ak plis · Tout sèks · Mizajou Jan 20, 2026 · NCT05366881

Molecular Analysis Of Solid Tumors

Ap rekriteEtid obsèvasyon
  • St. Jude Children's Research Hospital, Memphis
Jiska laj 25 · Tout sèks · Mizajou Nov 12, 2025 · NCT01050296

Etid Sarkom tisi mou nan lòt vil

Lòt etid nan Memphis

Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.